Web-based Mobile Health Application for Patients With Liver Cirrhosis (ReLiver-N App) (ReLiver-NApp)
Mobile Health, Liver Cirrhosis, Patient Activation
About this trial
This is an interventional supportive care trial for Mobile Health focused on measuring liver cirrhosis, mobile health, Patient Activation
Eligibility Criteria
Inclusion Criteria: Diagnosed with liver cirrhosis Had Child-Pugh A and B categories 18 years of age or older No barriers to verbal or written communication Having internet at home and a smartphone Patients who consented to participate in the study. Exclusion Criteria: Had Child-Pugh C category Had pregnant Liver transplanted Diagnosed with hepatocellular carcinoma Having dementia Having been diagnosed with a psychiatric disease
Sites / Locations
- Akdeniz UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
ReLiver-N App Group
Active Control Group
The ReLiver-N App will be introduced to the participants with liver cirrhosis during face-to-face interviews. The ReLiver-N App group will have access to all the contents of the ReLiver-N App, which includes the "about us", "patient education information about liver cirrhosis ", "patient activity skills", and "measuring tools". During the follow-up period, the participants in the ReLiver-N App group will take WhatsApp messages once a week and be reminded to use the education program. The ReLiver-N App will be asked to use it for three months on daily and weekly inputs their results. During the follow-up period, the participants can contact researcher via the 24/7 on the ReLiver-N App. The clinical researchers of the team will answer the participant' questions via WhatsApp. Participants in the ReLiver-N group will also receive routine patient education and routine hospital follow-ups given by the Gastroenterology team.
The ReLiver-N App will be introduced to the participants with liver cirrhosis in the active control group during face-to-face interviews. The active control group will have access to only these fields "about us", "patient activity skills", and "measuring tools". Participants in the active control group will also receive routine patient education and routine hospital follow-ups given by the Gastroenterology team during the three-month follow-up period.